Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udho Thadani

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The American Journal of Cardiology|February 5, 2003
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectorisCarl J Pepine, Rhonda M Cooper-DeHoff, Robert J Weiss, et al.
Journal of the American College of Cardiology|November 16, 2005
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trialRalph M Vicari, Bernard Chaitman, Deborah Keefe, et al.
Diabetes Care|November 15, 2007
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Henry R Black, Barry Davis, Joshua Barzilay, et al.
Clinical Cardiology|January 20, 2016
Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United StatesNish Patel, Nileshkumar J Patel, Badal Thakkar, et al.
Clinical Pharmacokinetics|June 21, 2002
Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarctionJohn B Kostis, Randy C Dockens, Udho Thadani, et al.
Journal of the American College of Cardiology|December 19, 2003
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trialCarl J Pepine, Jean-Lucien Rouleau, Karen Annis, et al.
Clinical Cardiology|August 10, 2013
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic functionPeter A McCullough, Denise Barnard, Robert Clare, et al.
Archives of Internal Medicine|June 29, 2005
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul K Whelton, Joshua Barzilay, William C Cushman, et al.
Circulation|October 5, 2011
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)Linda B Piller, Sarah Baraniuk, Lara M Simpson, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trialFrans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The American Journal of Cardiology|February 5, 2003
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectorisCarl J Pepine, Rhonda M Cooper-DeHoff, Robert J Weiss, et al.
Journal of the American College of Cardiology|November 16, 2005
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trialRalph M Vicari, Bernard Chaitman, Deborah Keefe, et al.
Diabetes Care|November 15, 2007
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Henry R Black, Barry Davis, Joshua Barzilay, et al.
Clinical Cardiology|January 20, 2016
Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United StatesNish Patel, Nileshkumar J Patel, Badal Thakkar, et al.
Clinical Pharmacokinetics|June 21, 2002
Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarctionJohn B Kostis, Randy C Dockens, Udho Thadani, et al.
Journal of the American College of Cardiology|December 19, 2003
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trialCarl J Pepine, Jean-Lucien Rouleau, Karen Annis, et al.
Clinical Cardiology|August 10, 2013
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic functionPeter A McCullough, Denise Barnard, Robert Clare, et al.
Archives of Internal Medicine|June 29, 2005
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul K Whelton, Joshua Barzilay, William C Cushman, et al.
Circulation|October 5, 2011
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)Linda B Piller, Sarah Baraniuk, Lara M Simpson, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trialFrans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
Pageof 4